delete National Health (Pharmaceutical Benefits) Regulations (Amendment)
Amendment to the National Health (Pharmaceutical Benefits) Regulations, affecting the PBS which subsidizes prescription drugs. Changes likely expand government intervention in pharmaceutical markets.
Maintains harmful subsidy program that distorts markets, raises costs for taxpayers, imposes compliance burdens, reduces competition, and inflates drug prices. The unseen consequences include reduced innovation and inefficient resource allocation.